Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.


PURPOSE Accurate tumor classification is essential for cancer management as patient outcomes improve with use of site- and subtype-specific therapies. Current clinicopathologic evaluation is varied in approach, yet standardized diagnoses are critical for determining therapy. While gene expression-based cancer classifiers may potentially meet this need… (More)
DOI: 10.1158/1078-0432.CCR-12-0920


6 Figures and Tables